COMPANY
Enrich Biosystems
Enrich Biosystems (https://enrichbiosystems.com/) has developed a bench-top laboratory instrument that enables short and long-term studies of interactions between living cells. We develop TROVO, a benchtop cell analysis and live cell recovery system that gives researchers a way to watch what their cells are doing — and retrieve the ones that matter. From company website Source · Oct 13, 2026
Funding and NIH signals
- SEC Form D raise Raised $1.45M in debt securities (Form D filed Nov 26, 2025). SEC Form D 0001931770-25-000002 (Nov 26, 2025)
Evidence (1 event)
- Nov 26, 2025 · SEC Form D 0001931770-25-000002
Name of Issuer: ENRICH BIOSYSTEMS INC.; CIK: 1931770; Address: Branford, CT; Submission type: D; Filing date: 2025-11-26; Industry Group: Biotechnology; Date of First Sale: 2025-11-13; Types of Securities Offered: Debt; Business combination transaction: false; Total Offering Amount: 1500000; Total Amount Sold: 1450000; Federal exemptions: 06b
- Nov 26, 2025 · SEC Form D 0001931770-25-000002